MICHELLE STEWART: Open Payments
NPI 1245976224 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,441 in 68 payments from 20 companies in 2025. Trend: 2023 $2,751 · 2024 $1,291 · 2025 $1,441
Food & beverage: $1,361Education: $80
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 7 | $197 |
| E.R. Squibb & Sons, L.L.C. | 11 | $174 |
| Actelion Pharmaceuticals US, Inc. | 3 | $112 |
| Novartis Pharmaceuticals Corporation | 5 | $108 |
| Amgen Inc. | 3 | $108 |
| Philips North America LLC | 5 | $105 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $105 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $71 |
| PFIZER INC. | 4 | $62 |
Products named: CARDIOMEMS, CAMZYOS, LEQVIO, Repatha, LifeVest, ELIQUIS, Ambulatory Monitoring & Diagnostics Undivided, OPSUMIT.
Industry payments across MS — which companies pay providers there.
